Galaxy Biomedical Investment Co. Ltd. A | Ownership
Companies that own Galaxy Biomedical Investment Co. Ltd. A
China Southern Asset Management Co., Ltd.
3,595,000
0.52%
939,800
0.02%
03/31/2018
The Vanguard Group, Inc.
863,800
0.12%
0
0%
07/31/2018
SWS MU Fund Management Co., Ltd.
288,731
0.04%
-3,900
0%
12/31/2017
GF Fund Management Co., Ltd.
275,600
0.04%
1,800
0%
12/31/2017
Harvest Fund Management Co., Ltd.
177,900
0.03%
18,500
0%
12/31/2017
China Asset Management Co., Ltd.
157,100
0.02%
-400
0%
12/31/2017
Tian Hong Asset Management Co., Ltd.
114,800
0.02%
3,200
0%
12/31/2017
Soochow Asset Management Co., Ltd.
104,000
0.02%
29,600
0.01%
12/31/2017
Penghua Fund Management Co., Ltd.
59,200
0.01%
-6,000
0%
12/31/2017
Da Cheng Fund Management Co., Ltd.
47,858
0.01%
-2,900
0%
12/31/2017
| Address |
Galaxy Software Technology Park
Beihai Guangzi Zhuang 536000
China
|
|
Employees
|
- |
| Website |
http://www.g-biomed.com |
| Updated |
07/08/2019 |
| Galaxy Biomedical Investment Co., Ltd. engages in the provision of investment in bio-pharmaceutical industry, transmission and distribution system industry, and electronic information industry. The company focuses on biotechnology and build its pharmaceutical and medical service industry structure; production and sale of transformer products; and manufacture of resistors, sensors, brake resistor box, radio frequency components, and potentiometers. The company was founded on June 20, 1993 and is headquartered in Beihai, China. |
